🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

HOTCHKIS & WILEY’s BIIB Holdings & Trades

First Buy
Q2 2016
Duration Held
28 Quarters
Largest Add
Q3 2026
+672,530 Shares
Current Position
672,530 Shares
$151.91 M Value

HOTCHKIS & WILEY's BIIB Position Overview

HOTCHKIS & WILEY (via Hotchkis & Wiley Capital Management LLC) currently holds 672,530 shares of Biogen Inc. (BIIB) worth $151.91 M, representing 0.43% of the portfolio. First purchased in 2016-Q2, this long-term strategic position has been held for 28 quarters.

Based on 13F filings, HOTCHKIS & WILEY has maintained a strategic position in BIIB, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2026, adding 672,530 shares. Largest reduction occurred in Q2 2021, reducing 197,311 shares.

Analysis based on 13F filings available since 2013 Q2

HOTCHKIS & WILEY's Biogen (BIIB) Holding Value Over Time

Track share changes against reported price movement

Quarterly Biogen (BIIB) Trades by HOTCHKIS & WILEY

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +672,530 New Buy 672,530 $225.88
Q4 2022 -1,800 Sold Out 0 $0.00
Q3 2022 +200 Add 12.50% 1,800 $267.22
Q2 2021 -197,311 Reduce 99.20% 1,600 $346.25
Q1 2021 -500 Reduce 0.25% 198,911 $279.75
Q4 2020 -4,900 Reduce 2.40% 199,411 $244.86
Q3 2020 -75,060 Reduce 26.87% 204,311 $283.68
Q2 2020 -100 Reduce 0.04% 279,371 $267.55
Q1 2020 +8,000 Add 2.95% 279,471 $316.38
Q4 2019 +33,399 Add 14.03% 271,471 $296.73
Q3 2019 +200 Add 0.08% 238,072 $232.82
Q2 2019 -2,500 Reduce 1.04% 237,872 $233.87
Q1 2019 -4,200 Reduce 1.72% 240,372 $236.38
Q4 2018 -8,600 Reduce 3.40% 244,572 $300.92
Q3 2018 -9,900 Reduce 3.76% 253,172 $353.31
Q2 2018 -4,600 Reduce 1.72% 263,072 $290.24
Q1 2018 -4,000 Reduce 1.47% 267,672 $273.82
Q4 2017 -3,100 Reduce 1.13% 271,672 $318.57
Q3 2017 -11,800 Reduce 4.12% 274,772 $313.12
Q1 2017 -228 Reduce 0.08% 286,572 $273.42
Q4 2016 -19,300 Reduce 6.31% 286,800 $283.58
Q3 2016 +77,100 Add 33.67% 306,100 $313.03
Q2 2016 +229,000 New Buy 229,000 $241.82

HOTCHKIS & WILEY's Biogen Investment FAQs

HOTCHKIS & WILEY first purchased Biogen Inc. (BIIB) in Q2 2016, acquiring 229,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

HOTCHKIS & WILEY has held Biogen Inc. (BIIB) for 28 quarters since Q2 2016.

HOTCHKIS & WILEY's largest addition to Biogen Inc. (BIIB) was in Q3 2026, adding 672,530 shares worth $151.91 M.

According to the latest 13F filing for Q3 2026, HOTCHKIS & WILEY's firm, Hotchkis & Wiley Capital Management LLC, owns 672,530 shares of Biogen Inc. (BIIB), valued at approximately $151.91 M.

As of the Q3 2026 filing, Biogen Inc. (BIIB) represents approximately 0.43% of HOTCHKIS & WILEY's publicly disclosed stock portfolio, making it one of their key holdings.

HOTCHKIS & WILEY's peak holding in Biogen Inc. (BIIB) was 672,530 shares, as reported at the end of Q3 2026.